BioMS May Give Lilly $5 Billion Cure for Expiring Drug Patents

Search Options	close
Search the following clips: All Clips

news science politics food economy art
technology health internet religion psychology

Sign Up Install Learn More Login


	BioMS May Give Lilly $5 Billion Cure for Expiring Drug Patents

Br1an75

12-29-2008 9:50 PM

114 views

tags:

biotechnology, multiple sclerosis, dirucotide, lilly, bioms

Add a Comment

Login to Comment. Not a member yet? Sign up

Today's Top Clips

visit the Top Clips page

View the Top Clips from December 29, 2008

Embed This Clip In Your Site...

<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/68be499c-7e0b-4380-ada0-6424a8ff3f61/ADDB3934-BA69-41F5-98AE-F8F20B5C6A6A/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.bloomberg.com/apps/news?pid=20601109&sid=aWth2ME0_ZNs&refer=home" href="http://www.bloomberg.com/apps/news?pid=20601109&sid=aWth2ME0_ZNs&refer=home" style="font-size: 11px;">www.bloomberg.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.bloomberg.com/apps/news?pid=20601109&sid=aWth2ME0_ZNs&refer=home"><div align="center"><img src="http://content9.clipmarks.com/blog_cache/www.bloomberg.com/img/10C6C116-2148-49CB-90E2-337F32D8870C" alt="Bloomberg" /></div></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.bloomberg.com/apps/news?pid=20601109&sid=aWth2ME0_ZNs&refer=home"><SPAN aria-level="0" aria-posinset="0" aria-setsize="0">BioMS May Give Lilly $5 Billion Cure for Expiring Drug Patents </SPAN></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.bloomberg.com/apps/news?pid=20601109&sid=aWth2ME0_ZNs&refer=home"><P aria-level="0" aria-posinset="0" aria-setsize="0">By Kelly Riddell</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.bloomberg.com/apps/news?pid=20601109&sid=aWth2ME0_ZNs&refer=home"><P aria-level="0" aria-posinset="0" aria-setsize="0">Dec. 26 (Bloomberg) -- <A aria-level="0" aria-posinset="0" aria-setsize="0" href="http://www.bloomberg.com/apps/quote?ticker=MS:CN" T_ABOVE="true" T_STATIC="true" T_FONTCOLOR="#000000" T_FONTFACE="Verdana,sans-serif" T_BGCOLOR="#ddedd9" T_WIDTH="110" T_DELAY="50">BioMS Medical Corp.,</A> a one-drug biotechnology company in Edmonton, Alberta, may hold a partial answer as to how <A aria-level="0" aria-posinset="0" aria-setsize="0" href="http://www.bloomberg.com/apps/quote?ticker=LLY:US" T_ABOVE="true" T_STATIC="true" T_FONTCOLOR="#000000" T_FONTFACE="Verdana,sans-serif" T_BGCOLOR="#ddedd9" T_WIDTH="110" T_DELAY="50">Eli Lilly & Co.</A> will replace $9.9 billion in sales threatened by expiring patents. </P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.bloomberg.com/apps/news?pid=20601109&sid=aWth2ME0_ZNs&refer=home"><P aria-level="0" aria-posinset="0" aria-setsize="0">Lilly signed a $497 million licensing and development agreement for BioMS’s dirucotide, potentially the first treatment for advanced forms of multiple sclerosis to come to market. The medicine, which entered final trials, has so far escaped side effects such as influenza-like symptoms, fatigue and skin cancer that were reported by Basel, Switzerland-based <A aria-level="0" aria-posinset="0" aria-setsize="0" href="http://www.bloomberg.com/apps/quote?ticker=NOVN:VX" T_ABOVE="true" T_STATIC="true" T_FONTCOLOR="#000000" T_FONTFACE="Verdana,sans-serif" T_BGCOLOR="#ddedd9" T_WIDTH="110" T_DELAY="50">Novartis AG</A> on fingolimod, another late-stage drug in testing for the disease. </P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.bloomberg.com/apps/news?pid=20601109&sid=aWth2ME0_ZNs&refer=home"><P aria-level="0" aria-posinset="0" aria-setsize="0">A mid-level study of <A aria-level="0" aria-posinset="0" aria-setsize="0" target="_blank" href="http://www.biomsmedical.com/" T_ABOVE="true" T_STATIC="true" T_FONTCOLOR="#000000" T_FONTFACE="Verdana,sans-serif" T_BGCOLOR="#ddedd9" T_WIDTH="120" T_DELAY="50">dirucotide</A>, involving 218 subjects, had “very impressive features to it,” according to <A aria-level="0" aria-posinset="0" aria-setsize="0" href="http://search.bloomberg.com/search?q=Bill+Chin%2C&site=wnews&client=wnews&proxystylesheet=wnews&output=xml_no_dtd&ie=UTF-8&oe=UTF-8&filter=p&getfields=wnnis&sort=date:D:S:d1" T_ABOVE="true" T_STATIC="true" T_FONTCOLOR="#000000" T_FONTFACE="Verdana,sans-serif" T_BGCOLOR="#ddedd9" T_WIDTH="110" T_DELAY="50">Bill Chin,</A> Lily’s vice president of discovery and clinical investigation. The drug represents a chance for “a breakthrough,” he said. </P></blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/ADDB3934-BA69-41F5-98AE-F8F20B5C6A6A/blog/" title="blog or email this clip"><img src="http://content6.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

New from the makers of Clipmarks: Amplify.com - Don't just share the news...Amplify it!

Clipmarks: Home; New Clips; Top Clips; Dashboard

Popular Topics: News; Life; Science; Technology; Entertainment

Get Started: Sign Up; Install Clipping Tool; How Clipping Works; Clip-to-Blog™; ClipSearch

Tools and Resources: FAQ; ClipWeek; Top Clippers; Top Tags; Site Map

About Clipmarks: About Us; Contact; Copyright; Privacy; EULA

Search Options

Today's Top Clips